↓ Skip to main content

Effect of Aripiprazole on Verbal Memory and Fluency in Schizophrenic Patients

Overview of attention for article published in CNS Drugs, September 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
87 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effect of Aripiprazole on Verbal Memory and Fluency in Schizophrenic Patients
Published in
CNS Drugs, September 2012
DOI 10.1007/s40263-012-0003-4
Pubmed ID
Authors

Chris Bervoets, Manuel Morrens, Kristof Vansteelandt, Frank Kok, Annick de Patoul, Veronique Halkin, Didier Pitsi, Eric Constant, Joseph Peuskens, Bernard Sabbe

Abstract

Second-generation antipsychotics have gradually replaced first-generation antipsychotics as first-line treatment for patients with schizophrenia. Some positive effects on verbal cognition have been shown for the second-generation antipsychotics, but most studies are based on relatively small numbers of patients.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 1%
Unknown 86 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 16%
Researcher 11 13%
Student > Doctoral Student 10 11%
Student > Master 9 10%
Other 8 9%
Other 16 18%
Unknown 19 22%
Readers by discipline Count As %
Psychology 19 22%
Medicine and Dentistry 18 21%
Agricultural and Biological Sciences 6 7%
Neuroscience 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 10 11%
Unknown 26 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2014.
All research outputs
#20,243,777
of 22,771,140 outputs
Outputs from CNS Drugs
#1,222
of 1,305 outputs
Outputs of similar age
#152,198
of 171,032 outputs
Outputs of similar age from CNS Drugs
#47
of 49 outputs
Altmetric has tracked 22,771,140 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,305 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,032 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.